ONCOSEC MEDICAL Inc Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2015 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
ONCOSEC MEDICAL Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2015 to Q4 2022.
- ONCOSEC MEDICAL Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending January 31, 2023 was -$6.86M, a 30.8% increase year-over-year.
- ONCOSEC MEDICAL Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending January 31, 2023 was -$32.7M, a 24.6% increase year-over-year.
- ONCOSEC MEDICAL Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$37.5M, a 21.2% increase from 2021.
- ONCOSEC MEDICAL Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$47.6M, a 10.3% decline from 2020.
- ONCOSEC MEDICAL Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was -$43.1M, a 42.4% decline from 2019.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)